ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $352,000 | +24.8% | 4,248 | 0.0% | 0.00% | +33.3% |
| Q1 2021 | $282,000 | -58.8% | 4,248 | -52.4% | 0.00% | -62.5% |
| Q4 2020 | $685,000 | +27.3% | 8,923 | -28.5% | 0.01% | +14.3% |
| Q3 2020 | $538,000 | -81.4% | 12,475 | -81.3% | 0.01% | -82.5% |
| Q2 2020 | $2,887,000 | +32.1% | 66,825 | -12.0% | 0.04% | +14.3% |
| Q1 2020 | $2,185,000 | -59.1% | 75,925 | -10.3% | 0.04% | -34.0% |
| Q4 2019 | $5,345,000 | +114.3% | 84,675 | -4.3% | 0.05% | +96.3% |
| Q3 2019 | $2,494,000 | +6.3% | 88,500 | 0.0% | 0.03% | +8.0% |
| Q2 2019 | $2,346,000 | +58.9% | 88,500 | +10.1% | 0.02% | +56.2% |
| Q1 2019 | $1,476,000 | +1254.1% | 80,400 | +900.0% | 0.02% | +1500.0% |
| Q2 2018 | $109,000 | – | 8,040 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |